Results 221 to 230 of about 4,628,908 (247)
Some of the next articles are maybe not open access.

Rare molecular subtypes of lung cancer

Nature Reviews Clinical Oncology, 2023
Oncogenes that occur in ≤5% of non-small-cell lung cancers have been defined as 'rare'; nonetheless, this frequency can correspond to a substantial number of patients diagnosed annually. Within rare oncogenes, less commonly identified alterations (such as HRAS, NRAS, RIT1, ARAF, RAF1 and MAP2K1 mutations, or ERBB family, LTK and RASGRF1 fusions) can ...
Guilherme Harada   +3 more
openaire   +2 more sources

Molecular Subtypes of Bladder Cancer

Current Oncology Reports, 2018
Recent whole genome characterizations of primary human bladder cancers revealed that they can be grouped into "intrinsic" basal and luminal molecular subtypes. Here, we provide an overview of the subtypes and discuss their biological and clinical properties.Basal cancers are characterized by advanced stage and metastatic disease at presentation.
David J, McConkey, Woonyoung, Choi
openaire   +2 more sources

Molecular Subtypes of Prostate Cancer

Current Oncology Reports, 2018
This review will examine the taxonomy of PCa subclasses across disease states, explore the relationship among specific alterations, and highlight current clinical relevance.Prostate cancer (PCa) is driven by multiple genomic alterations, with distinct patterns and clinical implications.
Kaveri, Arora, Christopher E, Barbieri
openaire   +2 more sources

Molecular subtypes of pancreatic cancer

Nature Reviews Gastroenterology & Hepatology, 2019
Cancers that appear morphologically similar often have dramatically different clinical features, respond variably to therapy and have a range of outcomes. Compelling evidence now demonstrates that differences in the molecular pathology of otherwise indistinguishable cancers substantially impact the clinical characteristics of the disease.
Eric A. Collisson   +3 more
openaire   +2 more sources

Molecular pharmacology of P2Y receptor subtypes

Biochemical Pharmacology, 2021
Professor Geoffrey Burnstock proposed the concept of purinergic signaling via P1 and P2 receptors. P2Y receptors are G-protein-coupled receptors (GPCRs) for extracellular adenine and uracil nucleotides. Eight mammalian P2Y receptor subtypes have been identified.
openaire   +2 more sources

Molecular Subtypes of Gliomas

2011
Gliomas are the most common primary brain tumors with heterogeneous morphology and variable prognosis. However, differences between histological subclasses and grades are subtle, and classifying gliomas is subject to a large inter-observer variability. This variability can result in misdiagnosis of gliomas.
Lonneke A.M. Gravendeel, Pim J. French
openaire   +1 more source

Molecular subtypes in cancers of the gastrointestinal tract

Nature Reviews Gastroenterology & Hepatology, 2017
Malignancies of the gastrointestinal tract are among the most common human cancers. The distinct tissues of origin give rise to a diverse set of diseases, such as colorectal cancer, pancreatic carcinoma and gastric cancers, with each associating with specific clinical features.
Maarten F, Bijlsma   +3 more
openaire   +2 more sources

Molecular analysis of HLA-B39 subtypes

Immunogenetics, 1993
Serological studies have suggested the presence of a new HLA-B39 subtype (B39.2) in the Japanese population. To identify the new HLA-B39 subtype and compare it with an other HLA-B39 subtype (B39.1), the genes encoding HLA-B39.1 (B*39013) and B39.2 (B*3902) have been cloned from Japanese.
N, Kato   +7 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy